According to Sangamo Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -160.78%. At the end of 2021 the company had an Operating Margin of -160.79%.
Year | Operating Margin | Change |
---|---|---|
2021 | -160.79% | 57.34% |
2020 | -102.19% | 9.69% |
2019 | -93.16% | 14.2% |
2018 | -81.57% | -45.34% |
2017 | -149.23% | -59.63% |
2016 | -369.65% | 214.82% |
2015 | -117.42% | 103.88% |
2014 | -57.59% | -47.8% |
2013 | -110.32% | 7.3% |
2012 | -102.81% | -70.38% |
2011 | -347.14% | 189.64% |
2010 | -119.85% | 37.05% |
2009 | -87.45% | -44.22% |
2008 | -156.77% | -42.42% |
2007 | -272.27% | 3.57% |
2006 | -262.89% | -52.5% |
2005 | -553.46% | -50.32% |
2004 | -1,114.07% | 144.13% |
2003 | -456.34% | -36.47% |
2002 | -718.26% | 128.15% |
2001 | -314.82% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 24.28% | -100.03% | ๐บ๐ธ USA |
![]() Amgen AMGN | 29.35% | -100.03% | ๐บ๐ธ USA |
![]() Biogen BIIB | 32.74% | -100.02% | ๐บ๐ธ USA |
![]() Dow DOW | 12.36% | -100.00% | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | 16.73% | -100.02% | ๐บ๐ธ USA |
![]() Merck MRK | 28.49% | -100.03% | ๐บ๐ธ USA |
![]() Alnylam Pharmaceuticals
ALNY | -100.93% | -100.18% | ๐บ๐ธ USA |
![]() BioMarin Pharmaceutical BMRN | 5.00% | -100.06% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.